Phase ii clinical trials clinical trials phase ii as topic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Cell Line, Tumor Tumor Cells, Cultured

Organisms2

Mice, Nude Coxiella

Diseases46

Neoplasms Lung Neoplasms Neoplasm Metastasis Disease Progression Breast Neoplasms Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Melanoma Brain Neoplasms Ovarian Neoplasms Kidney Neoplasms Prostatic Neoplasms Carcinoma, Renal Cell Liver Neoplasms Neutropenia Recurrence Adenocarcinoma Leukopenia Nausea Colorectal Neoplasms Thrombocytopenia Glioma Glioblastoma Pancreatic Neoplasms Drug-Related Side Effects and Adverse Reactions Vomiting Hematologic Diseases Fatigue Disease Models, Animal Stroke Peritoneal Neoplasms Stomach Neoplasms Head and Neck Neoplasms Carcinoma, Squamous Cell HIV Infections Diarrhea Acute Disease Pain Skin Neoplasms Carcinoma, Small Cell Sarcoma Asthenia Biliary Tract Neoplasms Carcinoma Chronic Disease Lymphoma, Non-Hodgkin

Chemicals and Drugs76

Antineoplastic Agents Epothilones Depsipeptides Deoxycytidine Antibodies, Monoclonal, Humanized Paclitaxel Taxoids Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Tetrahydroisoquinolines Cisplatin Dioxoles Aminoacridines Phenylurea Compounds Antimetabolites, Antineoplastic Fluorouracil Benzenesulfonates Quinazolines Niacinamide Antineoplastic Agents, Alkylating Angiogenesis Inhibitors Cancer Vaccines Doxorubicin Topotecan Pyridines Protein Kinase Inhibitors Camptothecin Placebos Pyrroles Tumor Markers, Biological Recombinant Proteins Organoplatinum Compounds Carboplatin Drug Combinations Antigens, Neoplasm Vinblastine Dacarbazine Enzyme Inhibitors Leucovorin Drugs, Investigational Indoles Cyclophosphamide Benzamides Etoposide Prodrugs Tegafur Acridines Oxonic Acid Epirubicin Ifosfamide Thalidomide Vincristine Receptor, Epidermal Growth Factor Pyrazines NAD(P)H Dehydrogenase (Quinone)Pyrimidines Biological Markers Antibodies, Monoclonal, Murine-Derived Bridged Compounds Prednisone Antibiotics, Antineoplastic Anthracyclines Boronic Acids Methotrexate Thiophenes Estramustine Piperazines Anticarcinogenic Agents Sulfonamides Guanine Granulocyte Colony-Stimulating Factor Interferon-alpha Immunologic Factors Antineoplastic Agents, Hormonal Prostate-Specific Antigen Quinolines

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Clinical Trials, Phase II as Topic Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase I as Topic Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Early Termination of Clinical Trials Clinical Trials, Phase III as Topic Research Design Drug Evaluation Disease-Free Survival Double-Blind Method Endpoint Determination Survival Analysis Infusions, Intravenous Combined Modality Therapy Administration, Oral Survival Rate Follow-Up Studies Randomized Controlled Trials as Topic Prospective Studies Neoplasm Staging Controlled Clinical Trials as Topic Injections, Intralesional Immunotherapy Kaplan-Meier Estimate Patient Selection Neoadjuvant Therapy Multicenter Studies as Topic Placebos Prognosis Drug Therapy, Combination Clinical Protocols Tumor Burden Xenograft Model Antitumor Assays Maximum Tolerated Dose Clinical Trials, Phase IV as Topic Single-Blind Method Sample Size Inhibitory Concentration 50 Pilot Projects Feasibility Studies Salvage Therapy Remission Induction Severity of Illness Index Chemotherapy, Adjuvant Drug Evaluation, Preclinical Treatment Failure Risk Factors Questionnaires Risk Assessment Reproducibility of Results Genetic Therapy Meta-Analysis as Topic Data Interpretation, Statistical Drug Approval Area Under Curve Cross-Over Studies Pain Measurement Drug Screening Assays, Antitumor Disease Models, Animal Random Allocation Phytotherapy Injections, Intravenous Molecular Targeted Therapy Exercise Therapy Retrospective Studies Injections, Subcutaneous Therapeutic Human Experimentation Analysis of Variance Predictive Value of Tests Radiotherapy, Adjuvant Cohort Studies Probability Models, Biological Statistics, Nonparametric Proportional Hazards Models Multivariate Analysis Models, Statistical Sensitivity and Specificity

Psychiatry and Psychology3

Patient Compliance Pain Cognitive Therapy

Phenomena and Processes17

Metabolic Detoxication, Phase II Time Factors Dose-Response Relationship, Drug Drug Resistance, Neoplasm Maximum Tolerated Dose Drug Synergism Inhibitory Concentration 50 Apoptosis Cell Proliferation Cell Survival Signal Transduction Area Under Curve Genetic Vectors Pain Probability Mutation Sensitivity and Specificity

Disciplines and Occupations6

Research Design Evidence-Based Medicine Outcome Assessment (Health Care)Medical Oncology Biomedical Research Therapeutic Human Experimentation

Anthropology, Education, Sociology and Social Phenomena7

Quality of Life Informed Consent Patient Education as Topic Drug Approval United States Food and Drug Administration National Cancer Institute (U.S.)National Institutes of Health (U.S.)

Technology, Industry, Agriculture2

Dietary Supplements Drug Industry

Humanities1

Quality of Life

Information Science7

Survival Rate Questionnaires Periodicals as Topic Data Interpretation, Statistical Review Literature as Topic Publishing Abstracting and Indexing as Topic

Named Groups2

Research Subjects Patient Dropouts

Health Care64

Clinical Trials, Phase II as Topic Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase I as Topic Early Termination of Clinical Trials Clinical Trials, Phase III as Topic Disease-Free Survival Double-Blind Method Survival Analysis Survival Rate Follow-Up Studies Randomized Controlled Trials as Topic Prospective Studies Controlled Clinical Trials as Topic Kaplan-Meier Estimate Patient Selection Multicenter Studies as Topic Clinical Protocols Clinical Trials Data Monitoring Committees Clinical Trials, Phase IV as Topic Single-Blind Method Sample Size Pilot Projects Feasibility Studies Severity of Illness Index Outcome Assessment (Health Care)Treatment Failure Cost-Benefit Analysis Risk Factors Questionnaires Risk Assessment Reproducibility of Results Patient Compliance Guidelines as Topic Safety Meta-Analysis as Topic Data Interpretation, Statistical Informed Consent Patient Education as Topic Intention to Treat Analysis Practice Guidelines as Topic Area Under Curve Placebo Effect Cross-Over Studies Congresses as Topic United States Food and Drug Administration Patient Participation Random Allocation Research Support as Topic Retrospective Studies Analysis of Variance National Cancer Institute (U.S.)Predictive Value of Tests Patient Satisfaction National Institutes of Health (U.S.)Bias (Epidemiology)Cohort Studies Probability Statistics, Nonparametric Proportional Hazards Models Age Factors Multivariate Analysis Models, Statistical Sensitivity and Specificity

Publication Characteristics1

Clinical Trial, Phase II

Geographicals2

United States Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Publication Characteristics Geographicals

Clinical Trials, Phase II as Topic Clinical Trials as Topic Clinical Trial, Phase II Treatment Outcome Antineoplastic Agents Clinical Trials, Phase I as Topic Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Epothilones Early Termination of Clinical Trials Clinical Trials, Phase III as Topic Research Design Drug Evaluation Disease-Free Survival Neoplasms Double-Blind Method Depsipeptides Deoxycytidine Endpoint Determination Survival Analysis Infusions, Intravenous Antibodies, Monoclonal, Humanized Metabolic Detoxication, Phase II Paclitaxel Taxoids Combined Modality Therapy Time Factors Dose-Response Relationship, Drug Antineoplastic Agents, Phytogenic Lung Neoplasms Antibodies, Monoclonal Administration, Oral Tetrahydroisoquinolines Cisplatin Survival Rate Follow-Up Studies Dioxoles Neoplasm Metastasis Randomized Controlled Trials as Topic Aminoacridines Prospective Studies Phenylurea Compounds Neoplasm Staging Disease Progression Controlled Clinical Trials as Topic Antimetabolites, Antineoplastic Fluorouracil Breast Neoplasms Benzenesulfonates Neoplasm Recurrence, Local Quinazolines Niacinamide Injections, Intralesional Antineoplastic Agents, Alkylating Drug Resistance, Neoplasm Carcinoma, Non-Small-Cell Lung Melanoma Immunotherapy Angiogenesis Inhibitors Cancer Vaccines Kaplan-Meier Estimate Brain Neoplasms Patient Selection Neoadjuvant Therapy Cell Line, Tumor Doxorubicin Topotecan Multicenter Studies as Topic Pyridines Protein Kinase Inhibitors Camptothecin Placebos Pyrroles Ovarian Neoplasms Prognosis Tumor Markers, Biological Kidney Neoplasms Prostatic Neoplasms Drug Therapy, Combination Carcinoma, Renal Cell Liver Neoplasms Clinical Protocols Tumor Burden Xenograft Model Antitumor Assays Maximum Tolerated Dose Recombinant Proteins Clinical Trials Data Monitoring Committees Clinical Trials, Phase IV as Topic Organoplatinum Compounds Single-Blind Method Sample Size Neutropenia Mice, Nude Drug Synergism Inhibitory Concentration 50 Recurrence Carboplatin Adenocarcinoma Pilot Projects Quality of Life

No FAQ available that match "phase ii clinical trials clinical trials phase ii as topic"